Entocort EC - Budesonide capsules - ASTRAZENECA - Oral form of corticosteroid for Tx of mild to moderate Crohn's disease

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2001年 / 36卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：774 / +
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetics of budesonide controlled ileal release capsules in children and adults with active Crohn's disease
    Lundin, PDP
    Edsbäcker, S
    Bergstrand, M
    Ejderhamn, J
    Linander, H
    Högberg, L
    Persson, T
    Escher, JC
    Lindquist, B
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (01) : 85 - 92
  • [32] Budesonide capsules prolong time to relapse in Crohn's disease patients with medically induced remission
    Sandborn, WJ
    Feagan, BG
    Lofberg, R
    Campieri, M
    Greenberg, GR
    Hanauer, SB
    GASTROENTEROLOGY, 2003, 124 (04) : A381 - A381
  • [33] Safety of budesonide capsules for the treatment of Crohn's disease: Post-marketing surveillance data
    Lichtenstein, GR
    Bengtsson, B
    Danilewitz, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S317 - S318
  • [34] Healthcare cost savings with budesonide controlled ileal release capsules (CIR) in Crohn's disease
    Lofberg, R
    Danielsson, A
    Floren, CH
    Borg, S
    Ericsson, K
    GASTROENTEROLOGY, 2001, 120 (05) : A749 - A749
  • [35] Budesonide CIR capsules in children and adults with Crohn's disease: A pharmacokinetic and tolerability study.
    Lindquist, B
    Linander, H
    Nilsson, M
    Persson, T
    GASTROENTEROLOGY, 1999, 116 (04) : A785 - A785
  • [36] Treatment of a chronic inflammatory bowel disease (Crohn's disease) with an oral glucocorticoid (budesonide)
    Hiddemann, W
    INTERNIST, 1996, 37 (02): : 195 - 196
  • [37] Pharmacokinetics and pharmaco-dynamics of oral budesonide in children with Crohn's disease
    Dilger, K
    Alberer, M
    Busch, A
    Enninger, A
    Behrens, R
    Koletzko, S
    Stern, M
    Beckmann, C
    Gleiter, CH
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (09) : 704 - 705
  • [38] Oral budesonide as maintenance treatment for Crohn's disease: A meta-analysis.
    Pilar, N
    Luis, G
    Ramon, MJ
    Julio, P
    GASTROENTEROLOGY, 1999, 116 (04) : A796 - A796
  • [39] TRAJECTORIES OF ORAL BUDESONIDE USE IN CROHN'S DISEASE COHORT OF TUSCAN PATIENTS
    Bertani, L.
    Ferraro, S.
    Bartolini, C.
    Convertino, I
    Giometto, S.
    Cappello, E.
    Valdiserra, G.
    Tillati, S.
    Blandizzi, C.
    Lucenteforte, E.
    Gini, R.
    Tuccori, M.
    Costa, F.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S166 - S166
  • [40] Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients
    Bertani, L.
    Ferraro, S.
    Bartolini, C.
    Convertino, I.
    Giometto, S.
    Cappello, E.
    Valdiserra, G.
    Tillati, S.
    Blandizzi, C.
    Lucenteforte, E.
    Gini, R.
    Tuccori, M.
    Costa, F.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S570 - S570
12345